# Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/hospitalizations-and-healthcare-costs-associated-with-rifaximin-versus-lactulose/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael L. Volk,Rebecca Burne,Annie Guérin,Sherry Shi,George J Joseph,Zeev Heimanson,Maliha Ahmad |
| Citations | 28 |
| DOI | 10.1080/13696998.2021.1877148 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1877148?needAccess=true |
| OpenAlex ID | https://openalex.org/W3122360650 |
| PMID | 33464935 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Sherry Shi](https://scholariq.org/researchers/sherry-shi/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)

## Paper topics

- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.